Skip to main content
. 2021 Oct 26;19:eAO6254. doi: 10.31744/einstein_journal/2021AO6254

Table 2. Clinical measures and outcomes of cancer patients with COVID-19.

Variable Total (%) Alive (%) Deceased (%) p value
Hospital admission, n (%) 73 (69.5) 30 (28.5) 43 (40.9) 0.001
Hospital length of stay, days 17.9±12.9 14.7±11.7 20.1±13.3 0.03
ICU admission, n (%) 35 (33) 4 (3.8) 31 (29.5) 0.001
ICU length of stay, days 4.7±6.8 0.5±2.2 8.4±7.4 0.001
Mechanical ventilation, n (%) 34 (32.3) 2 (1.9) 32 (30.4) 0.001
Disseminated intravascular coagulation, n (%) 3 (2.86) 0 3 (2.86) 0.001
Pneumonia, n (%) 49 (46.6) 14 (13.3) 35 (33.3) 0.001
Renal replacement therapy, n (%) 25 (23.8) 3 (2.8) 22 (20.9) 0.001
Septic shock, n (%) 31 (29.5) 1 (0.9) 30 (28.5) 0.001

Results expressed as absolute numbers and percent (%) or mean±standard deviation.

ICU: intensive care unit.